Crossmark

Availability and equity analysis of China’s National Reimbursement Drug List-negotiated drugs: a national cross-sectional analysis

Published Online: 2026-09-03

Authors

Liu, Yuhan

Lin, Xiaofeng

Hu, Jiahao

Li, Fen
License Information

Text and Data Mining valid from 2026-09-03

Accepted Manuscript valid from 2026-09-03
More Information

Article History

Received: 5 November 2025

Accepted: 11 August 2026

First Online: 3 September 2026

Declarations

Ethics approval and consent to participate: Not applicable.

Consent for publication: Not applicable.

Competing interests: The authors declare no competing interests.

Document is current